A survey of current physical therapy practices in wound care.

Ostomy Wound Manage

University of Mary, Bismarck, ND 58504, USA.

Published: February 2002

Few standardized treatment protocols are available to guide physical therapists through the rapidly changing area of wound care. To assess current physical therapy practices and to determine relationships between specific demographic data and evaluation/intervention techniques utilized in wound care, a questionnaire was developed that used a Likert scale (1 to 5) for responses, offering choices from "always" to "never." The questionnaire was sent to physical therapists at 170 clinical sites used by the University of Mary Program in Physical Therapy in Bismarck, ND. The final return rate was 48.1%. The most commonly used evaluation and intervention techniques were determined. Use of the rubor of dependency test, sharp debridement, enzymatic debridement, compression dressings, and autolytic debridement was found to have a significant (P < .05) relationship to the reported percentage of compromised wound care patients in a clinician's practice; whereas, years of clinician experience has a significant (P < .05) relationship to the use of monofilament testing and the use of electrical stimulation. Reasons for the differences observed, including the role of guidelines, need to be explored.

Download full-text PDF

Source

Publication Analysis

Top Keywords

wound care
16
physical therapy
12
current physical
8
therapy practices
8
physical therapists
8
physical
5
survey current
4
wound
4
practices wound
4
care
4

Similar Publications

Background: The Abbreviated Injury Scale (AIS) and Injury Severity Score (ISS) grade the severity of injuries and are useful for trauma audit and benchmarking. However, AIS coding is complex and requires specifically trained staff. A simple yet reliable scoring system is needed.

View Article and Find Full Text PDF

Hypertrophic scar (HS) is a common fibroproliferative disorders with no fully effective treatments. The conversion of fibroblasts to myofibroblasts is known to play a critical role in HS formation, making it essential to identify molecules that promote myofibroblast dedifferentiation and to elucidate their underlying mechanisms. In this study, we used comparative transcriptomics and single-cell sequencing to identify key molecules and pathways that mediate fibrosis and myofibroblast transdifferentiation.

View Article and Find Full Text PDF

Bone Tissue Engineering: From Biomaterials to Clinical Trials.

Adv Exp Med Biol

January 2025

Department of Stem Cells & Regenerative Medicine, Centre for Interdisciplinary Research, D Y Patil Education Society (Deemed to be University), Kolhapur, India.

Bone tissue engineering is a promising field that aims to rebuild the bone tissue using biomaterials, cells, and signaling molecules. Materials like natural and synthetic polymers, inorganic materials, and composite materials are used to create scaffolds that mimic the hierarchical microstructure of bone. Stem cells, particularly mesenchymal stem cells (MSCs), play a crucial role in bone tissue engineering by promoting tissue regeneration and modulating the immune response.

View Article and Find Full Text PDF

Patients that survive firearm injuries frequently require follow-up care. This study aims to explore demographic characteristics of patients presenting to the emergency department for post-firearm injury care and to understand the reasons for their return visits. This was a retrospective chart review of all emergency department and readmission patient encounters for post-firearm injury care during the study period, January 1, 2019 to December 31, 2022, at an urban safety net hospital.

View Article and Find Full Text PDF

Background: Although revascularization is first-line therapy for chronic limb-threatening ischemia (CLTI), there are no established treatments for patients in whom revascularization is not (or is a poor) option, including CLTI that has responded poorly to revascularization. This study verified the efficacy of the Rheocarna, a novel apheresis device, for no-option CLTI or poor-response CLTI after revascularization.

Methods And Results: This multicenter retrospective observational study analyzed 221 patients (221 limbs) with no- or poor-option CLTI (mean [±SD] age 71±10 years; males, 70.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!